Visual Abstract
breast cancer
METASTATIC DISEASE, BREAST CANCER
Published online Jul. 13, 2023.
Imaging using the human epidermal growth factor receptor 2 (HER2)–binding tracer Up to 20% of breast cancer cases have human epidermal growth factor receptor 2 (HER2) overexpression with or without HER2 oncogene amplification (Currently, treatment failure is relatively common, and cure remains rare in metastatic disease (ABY-025 was labeled with positron-emitting Trastuzumab resistance has been documented both as primary and as acquired, prominently in previously treated patients (The primary endpoint was to correlate [